查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1659414

全球分子品管市场

Molecular Quality Controls
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球分子品管市场规模将达到 3.199 亿美元

2024 年全球分子品管市场规模估计为 2.382 亿美元，预计 2030 年将达到 3.199 亿美元，2024 年至 2030 年的复合年增长率为 5.0%。独立控制是报告中分析的细分市场之一，预计在分析期结束时复合年增长率为 5.4%，达到 2.113 亿美元。在分析期内，控制设备部分的成长率预计将达到 4.4% 的复合年增长率。

美国市场规模估计为 6,550 万美元，中国市场预估年复合成长率为 4.7%

预计2024年美国分子品管市场价值将达到 6,550 万美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 5,000 万美元，2024-2030 年分析期间的复合年增长率为 4.7%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 4.7% 和 3.8%。在欧洲，德国的复合年增长率预计为 3.9%。

全球分子品管市场 - 主要趋势与驱动因素摘要

分子品管如何影响诊断的准确性？

分子品管透过确保分子诊断测试的准确性、可靠性和一致性在临床实验室和诊断中心发挥着至关重要的作用。这些控制用于监测核酸检测程序（包括 PCR、NGS 和其他分子检测）的性能，以确保检测结果的有效性。它可以帮助实验室遵守监管要求、维持高品质标准并检测诊断工作流程中的潜在问题。随着分子诊断在医疗保健中变得越来越重要，对严格品管的需求也随之增加。分子品管的应用涉及多个领域，包括传染病检查、肿瘤学、基因检测和个人化医疗。随着癌症和感染疾病等疾病变得越来越普遍，分子诊断测试变得越来越复杂，需要加强品管。分子品管确保诊断检测提供准确的结果，改善患者的治疗效果并增强医疗服务。

哪些趋势正在塑造分子品管市场？

影响分子品管市场的关键趋势包括分子诊断的快速进步、个人化医疗的日益普及以及对实验室业务法规遵从性的日益重视。即时PCR和次世代定序(NGS) 等分子诊断技术创新导致了更复杂的测试过程，需要严格的品管以确保可靠的性能。市场也越来越关注个人化医疗，准确的分子检测对于根据个别患者制定治疗方案至关重要。 FDA 和 CLIA 等监管机构要求在分子诊断中使用品管来确保测试结果的准确性和可重复性。这种监管环境正在推动实验室和诊断中心采用分子品管。此外，感染疾病和癌症的蔓延推动了对分子诊断的需求，进一步增加了对品管以维持高检测标准的需求。

市场区隔将如何影响分子品管？

产品类型包括独立控制、仪器特定控制和分析物特定控制，其中独立控制越来越受欢迎，因为它们能够检验整个测试过程。应用包括传染病检查、肿瘤学检测和基因检测，其中由于 COVID-19、流感等的检测数量很大，感染疾病诊断占很大比例。分子品管的最终用户包括诊断实验室、医院、研究机构和学术中心。由于临床护理对分子测试的需求很高，诊断实验室是最大的终端使用者群体。从地区来看，北美由于其先进的医疗基础设施、法规合规要求以及慢性病的高发性而占据市场主导地位。由于医疗保健投资的增加和分子诊断的应用不断增加，亚太地区正在经历快速成长。

哪些因素推动了分子品管市场的成长？

分子品管市场的成长受到多种因素的推动，包括分子诊断的应用日益广泛、检测技术的进步以及品质保证的严格监管要求。对于准确、可靠的诊断测试的需求推动了分子品管的需求。 NGS 和数位 PCR 等技术创新为开发更复杂的品管解决方案创造了机会。此外，对个人化医疗的日益关注以及感染疾病和癌症发病率的上升进一步加速了市场的成长。

部分

产品类型（独立控制、基于仪器的控制）；分析物类型（单分析物控制、多分析物控制）；应用（感染疾病、癌症、基因检测、其他应用）

受访公司范例（值得关注的33家公司）

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • SERO AS
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP22324

Global Molecular Quality Controls Market to Reach US$319.9 Million by 2030

The global market for Molecular Quality Controls estimated at US$238.2 Million in the year 2024, is expected to reach US$319.9 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of the analysis period. Growth in the Instrument-Specific Controls segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.5 Million While China is Forecast to Grow at 4.7% CAGR

The Molecular Quality Controls market in the U.S. is estimated at US$65.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.0 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Molecular Quality Controls Market - Key Trends and Drivers Summarized

How Are Molecular Quality Controls Shaping Diagnostic Accuracy?

Molecular quality controls play a crucial role in clinical laboratories and diagnostic centers by ensuring the accuracy, reliability, and consistency of molecular diagnostic tests. These controls are used to monitor the performance of nucleic acid testing procedures, including PCR, NGS, and other molecular assays, ensuring the validity of test results. They help laboratories comply with regulatory requirements, maintain high-quality standards, and detect any potential issues in diagnostic workflows. As molecular diagnostics become increasingly essential in healthcare, the need for stringent quality controls has intensified. The application of molecular quality controls spans across various domains such as infectious disease testing, oncology, genetic testing, and personalized medicine. With the rising prevalence of diseases such as cancer and infectious conditions, molecular diagnostic tests are becoming more sophisticated, demanding enhanced quality control measures. Molecular quality controls ensure that the diagnostic assays produce accurate results, leading to better patient outcomes and improved healthcare services.

What Trends Are Shaping the Molecular Quality Controls Market?

Key trends influencing the molecular quality controls market include the rapid advancements in molecular diagnostics, the increasing adoption of personalized medicine, and the growing emphasis on regulatory compliance in laboratory practices. Technological innovations in molecular diagnostics, such as real-time PCR and next-generation sequencing (NGS), have led to more complex testing processes, which require stringent quality controls to ensure reliable performance. The market is also witnessing an increased focus on personalized medicine, where accurate molecular testing is crucial for tailoring treatments to individual patients. Regulatory agencies such as the FDA and CLIA mandate the use of quality controls in molecular diagnostics to ensure the accuracy and reproducibility of test results. This regulatory landscape is driving the adoption of molecular quality controls across laboratories and diagnostic centers. Additionally, the increasing prevalence of infectious diseases and cancer is propelling demand for molecular diagnostics, further boosting the need for quality controls to maintain high testing standards.

How Do Market Segments Impact the Molecular Quality Controls Landscape?

Product types include independent controls, instrument-specific controls, and analyte-specific controls, with independent controls gaining popularity due to their ability to validate the entire testing process. Applications encompass infectious disease testing, oncology testing, and genetic testing, with infectious disease diagnostics accounting for a significant share due to the high volume of tests conducted for conditions like COVID-19 and influenza. End-users of molecular quality controls include diagnostic laboratories, hospitals, research institutions, and academic centers. Diagnostic laboratories represent the largest end-user segment due to the high demand for molecular testing in clinical settings. Geographically, North America dominates the market due to advanced healthcare infrastructure, regulatory compliance requirements, and a high prevalence of chronic diseases. The Asia-Pacific region is witnessing rapid growth due to increased healthcare investments and the rising adoption of molecular diagnostics.

What Factors Are Driving the Growth in the Molecular Quality Controls Market?

The growth in the molecular quality controls market is driven by several factors, including the increasing adoption of molecular diagnostics, advancements in testing technologies, and stringent regulatory requirements for quality assurance. The demand for accurate and reliable diagnostic tests is fueling the need for molecular quality controls. Technological innovations such as NGS and digital PCR are creating opportunities for the development of more sophisticated quality control solutions. Additionally, the growing focus on personalized medicine and the rising prevalence of infectious diseases and cancer are further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Molecular Quality Controls market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Independent Controls, Instrument-Specific Controls); Analyte Type (Single-Analyte Controls, Multi-Analyte Controls); Application (Infectious Diseases, Oncology, Genetic Testing, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • SERO AS
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Quality Controls - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accuracy and Reliability in Molecular Diagnostics Spurs Growth in Molecular Quality Controls Market
    • Technological Advancements in High-Sensitivity and Multi-Analyte Quality Controls Strengthen Business Case for Adoption
    • Expansion of Molecular Quality Controls in Infectious Disease Testing and Oncology Fuels Market Growth
    • Increasing Adoption of Molecular Quality Controls in Clinical Laboratories and Diagnostic Centers Expands Market Opportunities
    • Technological Innovations in Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) Controls Propel Market Expansion
    • Rising Focus on Enhancing Diagnostic Accuracy and Reducing False-Positive Rates Drives Demand for Molecular Quality Controls
    • Growing Use of Molecular Quality Controls in Genetic Testing and Personalized Medicine Expands Market Potential
    • Focus on Reducing Laboratory Errors and Enhancing Workflow Efficiency Strengthens Market for Molecular Quality Controls
    • Technological Advancements in Digital and Automated Quality Control Systems Propel Market Growth
    • Rising Demand for Molecular Quality Controls in Point-of-Care Testing (POCT) Strengthens Global Market
    • Expansion of Molecular Quality Controls in Biopharmaceutical and Research Applications Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Quality Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Quality Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Quality Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Independent Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Independent Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Independent Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instrument-Specific Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instrument-Specific Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instrument-Specific Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Single-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Single-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Single-Analyte Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Multi-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Multi-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Multi-Analyte Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Molecular Quality Controls Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Molecular Quality Controls by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Molecular Quality Controls by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION